NET PROFIT (x1000 SEK)
EMPLOYEES
Cell Biotech International A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
3,947
|
3,608
|
2,612 |
| Total assets |
42,135
|
36,917
|
27,130 |
| Current assets |
33,674
|
28,351
|
19,424 |
| Current liabilities |
20,473
|
18,932
|
13,482 |
| Equity capital |
21,662
|
17,808
|
13,049 |
| - share capital |
28,033
|
28,177
|
25,895 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
51.4%
|
48.2%
|
48.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
164.5%
|
149.8%
|
144.1% |
| Return on equity (ROE) |
18.2%
|
20.3%
|
20.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.